Therapeutics

Latest Innovations

Peptide Based Inhibitor of Calcium Current

 

This technology is a short fragment of a naturally occurring peptide that can be used to regulate the density of calcium current in mammalian cells. Modulation of...

Enhancement of Immune Response to Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Interferon Alpha

 

Porcine reproductive and respiratory syndrome (PRRS) is a major problem for hog farmers worldwide. PRRS is caused by a virus which leads to reproductive failure...

Glyburide as a Treatment for Anxiety

 

Dr. Freund is developing a method of treating anxiety with the diabetes drug, glyburide. By exploring the effects of anxiogenics like adenosine on the brain, Dr....

Therapeutic Cargo Delivery System for Treatment of Botulism Paralysis

 

Dr. Brenda Wilson has developed an anti-toxin that can be used for treatment of botulism. The botulinum toxin causes dangerous paralysis of motor neurons that can...

Therapeutic Scheme for Human Basigin

 

Cancer researchers are focusing their efforts on identifying central pathways that trigger or enhance the invasiveness of tumor cells. One such target is EMMPRIN...

Tissue Factor (TF) Nanodisc

 

This technology marries the Recombinant Human Tissue Factor (TF) with Membrane Scaffold Protein (MSP) Nanodiscs, resulting in an efficient and easy to administer...

A More Stable and Efficient Retroviral Gene Delivery Vector

 

This technology is a viral vector based on the murine leukemia virus (MLV), which has been favored for clinical gene therapy due to its preferential infectivity...

Less Toxic Amphotericin B Derivative

 

Researchers at the University of Illinois have developed a derivative of Amphotericin B that likely has a lower toxicity than the popular fungicide. The...

Self-Assembled Nanometer Scale Lipid Bilayers for Drug Discovery and Therapeutic Delivery

 

One of the most challenging problems in biochemical science are studies that involve membranes, including small molecules and proteins which are associated with...

Therapeutic Agents for Treatment of Myotonic Dystrophy

 

Dr. Zimmerman's lab has developed a series of bioactive compounds for the treatment of myotonic dystrophy. The compounds disrupt the MBNL-(CUG) foci in vivo and...

Pages